Your browser doesn't support javascript.
loading
AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.
Zhou, Fengbiao; Liu, Yi; Rohde, Christian; Pauli, Cornelius; Gerloff, Dennis; Köhn, Marcel; Misiak, Danny; Bäumer, Nicole; Cui, Chunhong; Göllner, Stefanie; Oellerich, Thomas; Serve, Hubert; Garcia-Cuellar, Maria-Paz; Slany, Robert; Maciejewski, Jaroslaw P; Przychodzen, Bartlomiej; Seliger, Barbara; Klein, Hans-Ulrich; Bartenhagen, Christoph; Berdel, Wolfgang E; Dugas, Martin; Taketo, Makoto Mark; Farouq, Daneyal; Schwartz, Schraga; Regev, Aviv; Hébert, Josée; Sauvageau, Guy; Pabst, Caroline; Hüttelmaier, Stefan; Müller-Tidow, Carsten.
Affiliation
  • Zhou F; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Liu Y; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg 69120, Germany.
  • Rohde C; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Pauli C; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg 69120, Germany.
  • Gerloff D; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Köhn M; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg 69120, Germany.
  • Misiak D; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Bäumer N; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Cui C; Institute of Molecular Medicine, University of Halle, Halle 06120, Germany.
  • Göllner S; Institute of Molecular Medicine, University of Halle, Halle 06120, Germany.
  • Oellerich T; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster 48149, Germany.
  • Serve H; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Garcia-Cuellar MP; Department of Hematology and Oncology, University of Halle, Halle 06120, Germany.
  • Slany R; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg 69120, Germany.
  • Maciejewski JP; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt Am Main 60590, Germany.
  • Przychodzen B; Department of Hematology, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
  • Seliger B; German Cancer Research Center and German Cancer, Consortium, Heidelberg 69120, Germany.
  • Klein HU; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt Am Main 60590, Germany.
  • Bartenhagen C; German Cancer Research Center and German Cancer, Consortium, Heidelberg 69120, Germany.
  • Berdel WE; Division of Genetics, Department of Biology, University of Erlangen-Nuremberg, Erlangen 91058, Germany.
  • Dugas M; Division of Genetics, Department of Biology, University of Erlangen-Nuremberg, Erlangen 91058, Germany.
  • Taketo MM; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, Ohio 44195, USA.
  • Farouq D; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, Ohio 44195, USA.
  • Schwartz S; Institute of Medical Immunology, University of Halle, Halle 06120, Germany.
  • Regev A; Institute of Medical Informatics, University of Muenster, Muenster 48149, Germany.
  • Hébert J; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts 02142, USA.
  • Sauvageau G; Institute of Medical Informatics, University of Muenster, Muenster 48149, Germany.
  • Pabst C; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster 48149, Germany.
  • Hüttelmaier S; Institute of Medical Informatics, University of Muenster, Muenster 48149, Germany.
  • Müller-Tidow C; Division of Experimental Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Nat Cell Biol ; 19(7): 844-855, 2017 Jul.
Article de En | MEDLINE | ID: mdl-28650479
ABSTRACT
Leukaemogenesis requires enhanced self-renewal, which is induced by oncogenes. The underlying molecular mechanisms remain incompletely understood. Here, we identified C/D box snoRNAs and rRNA 2'-O-methylation as critical determinants of leukaemic stem cell activity. Leukaemogenesis by AML1-ETO required expression of the groucho-related amino-terminal enhancer of split (AES). AES functioned by inducing snoRNA/RNP formation via interaction with the RNA helicase DDX21. Similarly, global loss of C/D box snoRNAs with concomitant loss of rRNA 2'-O-methylation resulted in decreased leukaemia self-renewal potential. Genomic deletion of either C/D box snoRNA SNORD14D or SNORD35A suppressed clonogenic potential of leukaemia cells in vitro and delayed leukaemogenesis in vivo. We further showed that AML1-ETO9a, MYC and MLL-AF9 all enhanced snoRNA formation. Expression levels of C/D box snoRNAs in AML patients correlated closely with in vivo frequency of leukaemic stem cells. Collectively, these findings indicate that induction of C/D box snoRNA/RNP function constitutes an important pathway in leukaemogenesis.
Sujet(s)
Prolifération cellulaire; Auto-renouvellement cellulaire; Transformation cellulaire néoplasique/métabolisme; Sous-unité alpha 2 du facteur CBF/métabolisme; Leucémies/métabolisme; Protéine de la leucémie myéloïde-lymphoïde/métabolisme; Protéines de fusion oncogènes/métabolisme; Petit ARN nucléolaire/métabolisme; Ribonucléoprotéines/métabolisme; Animaux; Transformation cellulaire néoplasique/génétique; Transformation cellulaire néoplasique/anatomopathologie; Protéines corépressives; Sous-unité alpha 2 du facteur CBF/génétique; DEAD-box RNA helicases/génétique; DEAD-box RNA helicases/métabolisme; Régulation de l'expression des gènes dans la leucémie; Prédisposition génétique à une maladie; Cellules HEK293; Cellules HL-60; Humains; Cellules K562; Leucémies/génétique; Leucémies/anatomopathologie; Méthylation; Souris de lignée C57BL; Souris knockout; Protéine de la leucémie myéloïde-lymphoïde/génétique; Protéines de fusion oncogènes/génétique; Phénotype; Cartes d'interactions protéiques; Protéines proto-oncogènes c-myc/génétique; Protéines proto-oncogènes c-myc/métabolisme; ARN ribosomique/génétique; ARN ribosomique/métabolisme; Petit ARN nucléolaire/génétique; Protéine-1 partenaire de translocation de RUNX1; Protéines de répression/génétique; Protéines de répression/métabolisme; Ribonucléoprotéines/génétique; Transduction du signal; Facteurs temps; Facteurs de transcription/génétique; Facteurs de transcription/métabolisme; Cellules U937

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ribonucléoprotéines / Leucémies / Protéines de fusion oncogènes / Transformation cellulaire néoplasique / Petit ARN nucléolaire / Prolifération cellulaire / Protéine de la leucémie myéloïde-lymphoïde / Sous-unité alpha 2 du facteur CBF / Auto-renouvellement cellulaire Type d'étude: Prognostic_studies Langue: En Journal: Nat Cell Biol Année: 2017 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ribonucléoprotéines / Leucémies / Protéines de fusion oncogènes / Transformation cellulaire néoplasique / Petit ARN nucléolaire / Prolifération cellulaire / Protéine de la leucémie myéloïde-lymphoïde / Sous-unité alpha 2 du facteur CBF / Auto-renouvellement cellulaire Type d'étude: Prognostic_studies Langue: En Journal: Nat Cell Biol Année: 2017 Type de document: Article Pays d'affiliation: Allemagne